Does breast cancer grade worsen with time? Evidence from breast screening

Breast Cancer Research and Treatment

Volumn 68, Issue 3, 2001, Pages 261-271

  Johnson, Ann ^a   Shekhdar, Jane ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Breast screening; Histological grade; Tumour growth rate

Indexed keywords

ARTICLE; BREAST TUMOR; DECISION SUPPORT SYSTEM; DISEASE COURSE; FEMALE; HUMAN; MASS SCREENING; PATHOLOGY; PROGNOSIS; TIME;

BREAST NEOPLASMS; DECISION SUPPORT TECHNIQUES; DISEASE PROGRESSION; FEMALE; HUMAN; MASS SCREENING; PROGNOSIS; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0035431950     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012273922325     Document Type: Article

References (22)

1. Tabár L, Duffy SW, Vitak B, Chen H-H, Prevost TC: The natural history of breast carcinoma. What have we learned from screening? Cancer 86: 449-462, 1999
2. Tubiana M, Koscielny S: The rationale for the early diagnosis of cancer. The example of breast cancer. Acta Oncol 38: 295-303, 1999
3. Millis RR, Barnes DM, Lampejo OT, Egan MK, Smith P: Tumour grade does not change between primary and recurrent mammary carcinoma. Eur J Cancer 34: 548-553, 1998
4. Andersen J, Poulsen HS: Relationship between estrogen receptor status in the primary tumor and its regional and distant metastases. An immunohistochemical study in human breast cancer. Acta Oncol 27: 761-765, 1988
5. Roylance R, Gorman P, Harris W, Liebmann R, Barnes D, Hanby A, Sheer D: Comparative genomic hybridization of breast tumours stratified by histological grade reveals new insights into the biological progression of breast cancer. Cancer Res 59: 1433-1436, 1999
6. Johnson AE, Shekhdar J: Interval cancers in the National Health Service Breast Screening Programme. Br J Radiol 68: 862-869, 1995
7. Charbit A, Malaise EP, Tubiana M: Relation between the pathological nature and the growth rate of human tumours. Eur J Cancer 7: 307-315, 1971
8. Johnson AE, Bennett MH, Cheung CWD, Cox SJ, Sales JELS: The management of individual breast cancers. The Breast 4: 100-111, 1995
9. Elston CW: Grading of invasive carcinoma of the breast. In: Page DL, Anderson TJ (eds) Diagnostic Histopathology of the Breast. Churchill Livingstone, Edinburgh, London, Melbourne, New York, 1987, pp 300-311
10. Cheung CWD, Johnson AE: Carcinoma of the breast: measurement and the management of treatment. II. The regression of tumours. Br J Radiol 64: 121-132, 1991
11. Woodman CBJ, Threlfall AG, Boggis CRM, Prior P: Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme's north western region. BMJ 310: 224-226, 1995
12. Collins VP, Loeffler MD, Tivey H: Observations on growth rates of human tumors. Am J Roetgenol 76: 988-1000, 1956
13. Tabár L, Fagerberg G, Duffy SW, Day NE, Gad A, Gröntoft O: Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clinics of North Am 30: 187-210, 1992
14. Tubiana M, Koscielny S: The natural history of breast cancer: implications for a screening strategy. Int J Radiation Oncol Biol Phys 19: 1117-1120, 1990
15. Steel GG: Growth Kinetics of Tumours. Clarendon Press, Oxford, 1977
16. Bloom HJG, Richardson WW: Histological grading and prognosis in breast cancer. Br J Cancer 11: 359-377, 1957
17. Koscielny S, Tubiana M, Lê MG, Valleron AJ, Mouriesse H, Contesso G, Sarrazin D: Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination. Br J Cancer 49: 709-715, 1984
18. Bloom HJG: Prognosis in carcinoma of the breast. Br J Cancer 4: 259-367, 1950
19. Duffy SW, Tabár L, Fagerberg G, Gad A, Gröntoft O, South MC, Day NE: Breast screening, prognostic factors and survival - results from the Swedish two county study. Br J Cancer 64: 1133-1138, 1991
20. Connor AJM, Pinder SE, Elston CW, Bell JA, Wencyk P, Robertson JFR, Blarney RW, Nicholson RI. Ellis IO: Intratumoral heterogeneity of proliferation in invasive breast carcinoma evaluated with MIB1 antibody. The Breast 6: 171-176, 1997
21. Teixera MR, Pandis N, Bardi G, Andersen JA, Mitelman F, Heim S: Clonal heterogeneity in breast cancer: karyotypic comparisons of multiple intra and extra-tumourous samples from 3 patients. Int J Cancer 63: 63-68, 1995
22. Johnson AE: Riposte to guest commentaries on 'Problems associated with randomized controlled clinical trials in breast cancer'. J Eval Clin Pract 4: 231-236, 1998